孕酮在辅助生殖技术中的临床应用
详细信息    查看全文 | 推荐本文 |
  • 作者:范新峰 ; 腊晓琳
  • 中文刊名:XJYI
  • 英文刊名:Xinjiang Medical Journal
  • 机构:新疆医科大学;
  • 出版日期:2018-08-25
  • 出版单位:新疆医学
  • 年:2018
  • 期:v.48
  • 基金:中华医学会临床医学科研专项资金-生殖医学青年医师研究与发展项目(编号17020500719)
  • 语种:中文;
  • 页:XJYI201808004
  • 页数:4
  • CN:08
  • ISSN:65-1070/R
  • 分类号:17-20
摘要
<正>孕酮在早孕中的重要性多年来就已经知道了。在体外受精-胚胎移植中进行黄体支持是常规的治疗方案。在妊娠第七周前去除黄体可引起流产,这可以通过给予外源性孕酮来预防。因此,孕酮的临床应用研究长盛不衰。1黄体酮在体外受精后黄体期支持中的作用自20世纪80年代以来,这一点已广为人知,目前普遍认为,在缺乏外源性激素支持的情况下,IVF周期后的黄体期以早期黄体溶解为特征,其次是雌激素和孕激素水平的过早下降。这些异常对子
        
引文
[1]Smitz J,Erard P,Camus M,Devroey P,Tournaye H,Wisanto A,et al.Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or?are-up protocol.Hum Reprod.1992;7:1225 9.
    [2]Albano C,Grimbizis G,Smitz J,Riethm褷uller-Winzen H,Reissmann T,Van Steirteghem A,et al.The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix.Fertil Steril.1998;70:357 9.
    [3]Beckers NG,Macklon NS,Eijkemans MJ,Ludwig M,Felberbaum RE,Diedrich K,et al.Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin,recombinant luteinizing hormone,or gonadotropin-releasing hormone(Gn RH)agonist to induce?nal oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and Gn RH antagonist cotreatment.J Clin Endocrinol Metab.2003;88:4186 92.
    [4]Tarlatzis BC,Fauser BC,Kolibianakis EM,Diedrich K,Rombauts L,Devroey P,et al.GnRH antagonists in ovarian stimulation for IVF.Hum Reprod Update.2006;12:333 40.
    [5]Fauser BC,Devroey P.Reproductive biology and IVF:ovarian stimulation and luteal phase consequences.Trends Endocrinol Metab.2003;14:236 42.
    [6]Van der Linden M,Buckingham K,Farquhar C,Kremer JA,Metwally M.Luteal phase support for assisted reproduction cycles.Cochrane Database Syst Rev.2011;(10):CD009154.
    [7]Chakravarty BN,Shirazee HH,Dam P,Goswami SK,Chatterjee R,Ghosh S.Oral dydrogesterone versus intravaginal micronized progesterone as luteal phase support in assisted reproductive technology(ART)cycles:results of a randomized study.J Steroid Biochem Mol Biol.2005;97:416 20.
    [8]Fatemi HM,Bourgain C,Donoso P,Blockeel C,Papanikolaou EG,Popovic-Todorovic B,et al.Effect of oral administration of dydrogesterone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profle in patients with premature ovarian failure:a proof of concept.Hum Reprod.2007;22:1260 3.
    [9]Pritts EA,Atwood AK.Luteal phase support in infertility treatment:a meta-analysis of the randomized trials.Hum Reprod.2002;17:2287 99.
    [10]Veysman B,Vlahos I,Oshva L.Pneumonitis and eosinophilia after in vitro fertilization treatment.Ann Emerg Med.2006;47:472 5.
    [11]Zarutskie PW,Phillips JA.A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology:vaginal versus intramuscular progesterone.Fertil Steril.2009;92:163 9.
    [12]Cicinelli E,Schonauer LM,Galantino P,Matteo MG,Cassetta R,Pinto V.Mechanisms of uterine specifcity of vaginal progesterone.Hum Reprod.2000;15:15965.
    [13]Kahraman S,Karagozoglu SH,Karlikaya G.The effciency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles:a prospective clinical trial.Fertil Steril.2010;94:761 3.
    [14]Polyzos NP,Messini CI,Papanikolaou EG,Mauri D,Tzioras S,Badawy A,et al.Vaginal progesterone gel for luteal phase support in IVF/ICSI cycles:a meta-analysis.Fertil Steril.2010;94:2083 7.
    [15]Silverberg KM,Vaughn TC,Hansard LJ,Burger NZ,Minter T.Vaginal(Crinone8%)gel vs.Intramuscular progesterone in oil for luteal phase support in in vitro fertilization:a large prospective trial.Fertil Steril.2012;97:344 8.
    [16]Mochtar MH,Van Wely M,Van der Veen F.Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.Hum Reprod.2006;21:905 8.
    [17]Williams SC,Oehninger S,Gibbons WE,Van Cleave WC,Muasher SJ.Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization:a randomized,prospective study.Fertil Steril.2001;76:1140 3.
    [18]Nyboe Andersen A,Popovic-Todorovic B,Schmidt KT,Loft A,Lindhard A,H?jgaard A,et al.Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates:a randomized controlled trial.Hum Reprod.2002;17:357 61.
    [19]Glujovsky D,Pesce R,Fiszbajn G,Sueldo C,Hart RJ,Ciapponi A.Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes.Cochrane Database Syst Rev.2010;(1):CD006359.
    [20]Kaser DJ,Ginsburg ES,Missmer SA,Correia KF,Racowsky C.Intramuscular progesterone versus 8%Crinone vaginal gel for luteal phase support for day 3cryopreserved embryo transfer.Fertil Steril.2012;98:1464 9.
    [21]Romero Nieto MI,Lorente Gonz alez J,Arjona-Berral JE,Del Mu~noz-Villanueva M,Castelo-Branco C.Luteal phase support with progesterone in intrauterine insemination:a prospective randomized study.Gynecol Endocrinol.2014;30:197 201.
    [22]]Miralpeix E,Gonz alez-Comadran M,Sol a I,Manau D,Carreras R,Checa MA.Ef?cacy of luteal phase support with vaginal progesterone in intrauterine insemination:a systematic review and meta-analysis.J Assist Reprod Genet.2014;31:89 100.
    [23]Seckin B,Turkcapar F,Yildiz Y,Senturk B,Yilmaz N,Gulerman C.Effect of luteal phase support with vaginal progesterone in intrauterine insemination cycles with regard to follicular response:a prospective randomized study.J Reprod Med.2014;59:260 6.
    [24]潘丽,庞丽萍,苏玉梅,徐丽华.妇科养荣胶囊治疗排卵障碍性不孕的临床观察[J].新疆医学,2015,45(02):201-203.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700